- 7.8k views
Cancer Risks in Diabetic Patients: What to Know
Diabetes, particularly Type 2, has been linked to an increased risk of certain cancers, including liver, pancreas, breast, and colon cancer. High blood sugar levels, insulin resistance, and chronic inflammation associated with diabetes can create a favorable environment for cancer cell growth. Additionally, certain diabetes medications and lifestyle factors may influence cancer risk. Early detection and regular screenings are crucial for diabetic patients to manage these risks. Adopting a healthy lifestyle, including a balanced diet, physical activity, and weight management, can help reduce the likelihood of cancer in diabetic individuals. Working closely with healthcare providers ensures comprehensive care and proactive monitoring.
About the Speaker
Dr. Priyasha Damodara
Medical Director, Oncoclarity, Co-founder Paxa Health, Bengaluru
Dr. Priyasha Damodara is a Radiation Oncologist with expertise in Neuro-Oncology, Precision Oncology, and Gynaecological Oncology. With an overall experience of over 9 years, Dr. Priyasha Damodara is currently a Consultant at Medicover Cancer Institute, Hyderabad and is also the Founder at Oncoclarity, a second opinion platform. She studied her MBBS from the prestigious Osmania Medical College, Post graduation in Radiation Oncology from Mahatma Gandhi Cancer Hospital and Research Institute and previously worked at HCG hospitals. With extensive experience in advanced radiotherapy techniques, including Stereotactic Radiosurgery, Stereotactic Body Radiotherapy, Image-Guided Adaptive Radiotherapy, and Brachytherapy, Dr. Priyasha Damodara specializes in integrating cutting-edge technology and medicine with personalized patient care. A prolific contributor to the field of oncology, Dr. Damodara has authored numerous publications in National and International journals and is also a contributory author to the 1st South Asian Edition of Devita, Hellman, and Rosenberg's Cancer Principles and Practice of Oncology Review
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr. Priyasha Damodara's Talks on Assimilate
- 10th -Dec -2024, TIME : 5:00PM TO 6:00 PM
- 0
Diabetes, particularly Type 2, has been linked to an increased risk of certain cancers, including liver, pancreas, breast, and colon cancer. High blood sugar levels, insulin resistance, and chronic inflammation associated with diabetes can create a favorable environment for cancer cell growth. Additionally, certain diabetes medications and lifestyle factors may influence cancer risk. Early detection and regular screenings are crucial for diabetic patients to manage these risks. Adopting a healthy lifestyle, including a balanced diet, physical activity, and weight management, can help reduce the likelihood of cancer in diabetic individuals. Working closely with healthcare providers ensures comprehensive care and proactive monitoring.